InvestorsHub Logo
Followers 62
Posts 1712
Boards Moderated 0
Alias Born 08/08/2005

Re: asmarterwookie post# 295770

Wednesday, 04/26/2017 11:27:15 AM

Wednesday, April 26, 2017 11:27:15 AM

Post# of 345789
Can you imagine Bavituximab approval on PI/II data?

Yes. More than imagine. It coheres with Peregrine's developing alignment with top labs like Dr. Wolchok's Memorial Sloan Kettering, producing anti-PS data accommodating new clinical trials through the NCCN and further collaborations/partnerships going forward.

Phase1 Approval

There is already a large volume of accumulated data for active arm Bavituximab efficacy and safety from Peregrine's clinical trials.

Dr. Wolchok was quick to add that FDA approvals can now come through results of a phase1 clinical trial. He's certainly stoked on the future possibilities for I-O.

IMO

sunstar

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News